Chevron Corporation
NYSE:CVXOil & Gas Integrated
-$4.04 today
- Market cap
- $401.70B
- Beta
- 0.47
- P/E (TTM)
- 31.2
- EPS (TTM)
- $5.56
- Dividend yield
- 4.02%
Volume 9.74M
Average 11.19M
CVX EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Chevron CorporationNYSE: CVX
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA growth accelerates
Q3 FY2026 EBITDA of $20.2B rose 74.7% year over year, ahead of the +59.1% change in trailing-twelve-month EBITDA. Sequentially, it fell 12.6% from the prior quarter. Over 3 fiscal years it compounded at -14.8% a year.
Context
- EBITDA amounted to 22.3% of revenue in FY2025, down 1.2 pp from a year earlier.
- EBITDA increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 10 analysts of $73.25B (+78.3%) for the fiscal year ending Dec 2026, a step up from the -9.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $20.2B-12.6% QoQ
- Last fiscal yearDec 2025
- $41.09B-9.5% YoY
- LTMSep 2026
- $64.26B+59.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +74.7% | +108.1% | +33.4 pp |
| 1 year | -9.5% | +78.3% | +87.7 pp |
| 3-year CAGR | -14.8% | +10.3% | +25.1 pp |
| 5-year CAGR | +6.4% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 41.09B USD
- Year-over-year change
- -9.5%
- 4-year CAGR
- +0.5%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 41.09B | -9.5% |
| FY2024 | 2024-12-31 | 45.38B | -4.2% |
| FY2023 | 2023-12-31 | 47.38B | -28.8% |
| FY2022 | 2022-12-31 | 66.51B | +65.1% |
| FY2021 | 2021-12-31 | 40.28B | — |
EBITDA vs competitors
How CVX compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +59.1% is the highest of 9, against a peer median of +23.4%.
- EBITDA amounts to 28.5% of revenue for CVX, versus a peer median of 21.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $71.83B USD | +1.7% | -12.9% | 19.9% | |
| LTM Jun 2026 | $67.91B USD | +27.9% | -15.1% | 22.9% | |
| LTM Sep 2026 | $64.26B USD | +59.1% | -14.8% | 28.5% | |
| LTM Sep 2026 | $47.49B USD | +50.2% | -1.7% | 19.9% | |
| LTM Jun 2026 | $46.6B USD | +20.8% | -13.0% | 23.7% | |
| LTM Jun 2026 | $45.29B USD | +10.6% | -25.0% | 39.9% | |
| LTM Jun 2026 | CA$20.15B CAD | +28.7% | -14.7% | 34.1% | |
| LTM Sep 2026 | €11.62B EUR | -19.9% | -11.2% | 13.1% | |
| LTM Sep 2026 | CA$10.03B CAD | +25.9% | -15.4% | 18.1% | |
| Peer median (excluding CVX) | — | +23.4% | -13.8% | 21.4% | |
Competitors are the stored peer set for CVX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 155.61B | 235.72B | 196.91B | 193.41B | 184.43B |
| Cost of Revenue | 110.17B | 170.13B | 136.52B | 136.49B | 128.35B |
| Gross Profit | 45.43B | 65.59B | 60.39B | 56.93B | 56.09B |
| Gross Margin | 29.2% | 27.8% | 30.7% | 29.4% | 30.4% |
| Research & Development | 268M | 268M | 320M | 353M | 427M |
| Selling, General & Admin | 4.01B | 4.31B | 4.14B | 4.83B | 5.13B |
| Operating Expenses | 29.33B | 25.64B | 26.6B | 27.83B | 39.41B |
| Depreciation & Amortization | 17.93B | 16.32B | 17.33B | 17.28B | 20.13B |
| EBITDA | 40.28B | 66.51B | 47.38B | 45.38B | 41.09B |
| EBITDA Margin | 25.9% | 28.2% | 24.1% | 23.5% | 22.3% |
| Operating Income | 16.1B | 39.95B | 33.79B | 29.1B | 16.67B |
| Operating Margin | 10.3% | 16.9% | 17.2% | 15.0% | 9.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 712M | 516M | 469M | 594M | 1.22B |
| Other Income / Expenses | 5.54B | 9.72B | (4.21B) | (1.59B) | 3.07B |
| Income Before Tax | 21.64B | 49.67B | 29.58B | 27.51B | 19.74B |
| Pre-Tax Margin | 13.9% | 21.1% | 15.0% | 14.2% | 10.7% |
| Income Tax Expense | 5.95B | 14.07B | 8.17B | 9.76B | 7.26B |
| Net Income | 15.63B | 35.47B | 21.37B | 17.66B | 12.3B |
| Net Margin | 10.0% | 15.0% | 10.9% | 9.1% | 6.7% |
| EPS (Basic) | 8.15 | 18.36 | 11.41 | 9.76 | 6.65 |
| EPS (Diluted) | 8.14 | 18.28 | 11.36 | 9.72 | 6.63 |
| Weighted Avg Shares | 1.92B | 1.93B | 1.87B | 1.81B | 1.85B |
| Weighted Avg Shares (Diluted) | 1.92B | 1.94B | 1.88B | 1.82B | 1.86B |
Chevron Corporation
NYSE:CVX
Intrinsic Alpha fair value
Locked
Current Price
$205.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.